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S1
General experimental details 
Synthesis. All commercially available chemicals were used without further purification. Moisture 
sensitive reactions were performed in flame-dried glassware under an atmosphere of nitrogen. 
Dichloromethane (DCM) and tetrahydrofuran (THF) were dried using an M. Braun SPS-800 
solvent purification system. Flash chromatography was performed with Macherey-Nagel Silica 
60 M (40−63 μm); the employed eluent is reported in parentheses (volumetric ratios, P = 
pentane). Thin-layer chromatography (TLC) was performed on precoated silica gel plates with 
fluorescence‐indicator UV254 (Merck Kieselgel 60 F254), and components were visualized by 
observation under UV light or by treating the plates with KMnO4 solution or CAM (cerium 
ammonium molybdate in diluted sulfuric acid) followed by heating. NMR spectra were obtained 
on Varian AMX400 and Agilent Technologies 400‐MR spectrometers operating at 400 MHz for 
1
H NMR spectra; 
13
C NMR spectra were recorded at 101 MHz. Chemical shifts are reported in 
ppm relative to residual solvent signals (δH 7.26 and δC 77.16 for CDCl3, δH 2.50 and δC 39.52 for 
DMSO-d6). Multiplicity is indicated as follows: s (singlet); bs (broad singlet); d (doublet); t 
(triplet); q (quartet); m (multiplet); dd (doublet of doublets), etc. High resolution mass spectra 
were obtained on a Thermo scientific LTQ Orbitrap XL (ESI ionization). Melting points were 
determined using a Buchi melting point B-545 apparatus.  
Irradiation experiments. Photochemical experiments were carried out at 20 °C unless stated 
otherwise. UV-Vis absorption spectra were recorded on Hewlet-Packard HP 8453 and Jasco V-
630 spectrophotometers in 10 mm quartz cuvettes using DMSO (J.T.Baker, Baker Analyzed), 
aqueous buffer solution (a mixture of Bis-TRIS, TRIS, MES and sodium acetate, 2 mM each, pH 
adjusted to 7.4) and LB growth medium (see details for experiments on bacteria). Irradiation was 
performed using Spectroline ENB-280C/FE UV lamps (365 nm), a Thorlabs model M365F1 
LED (365 nm, 4.1 mW), a Sahlmann Photochemical Solution LED system (400 nm: 3 × 
330 mW, FWHM 13.5 nm; 527 nm: 3 × 270 mW, FWHM 35.1 nm; 652 nm: 3 × 400 mW, 
FWHM 26.4 nm) and a Thorlabs OSL1-EC Fiber Illuminator (white light), also used in 
combination with a filter cutting off wavelength below 530 nm (white light ≥ 530 nm). UHPLC-
MS analysis was conducted on a ThermoFischer Scientific Vanquish UHPLC System (RP 
column: Acquity UPLC HSS T3 1.8 µm, 2.1 × 150 mm; eluent: 0.1% aqueous formic acid [A] 
and acetonitrile with 0.1% formic acid [B] using a linear gradient of 5% B to 90% B over 8 min) 
in combination with an LCQ Fleet mass spectrometer. 
 
S2
Synthesis of diaminopyrimidines 2a-j 
 




Aniline S1 (657 mg, 3.00 mmol, 1 eq.) was added to a solution of nitrosobenzene (482 mg, 
4.50 mmol, 1.5 eq.) in 15 mL glacial acetic acid under nitrogen atmosphere. The reaction mixture 
was stirred at 90 °C for 4 h, before it was allowed to cool to room temperature and poured into 
water. After the addition of a small amount of brine, the aqueous layer was repeatedly extracted 
with dichloromethane and the combined organic layers were successively washed with water, 
saturated aqueous NaHCO3 solution, water and brine, and dried over Na2SO4. Concentration of 
the organic layer under reduced pressure and purification by flash chromatography (DCM) gave 
azobenzene S2 as a red crystalline solid (658 mg, 2.14 mmol, 71%). 
TLC: Rf = 0.79 (DCM/P 7:3). 
1
H NMR (400 MHz, CDCl3): δ 8.01 – 7.88 (m, 6H), 7.56 – 7.45 
(m, 3H), 1.38 (s, 12H). 
13
C NMR (101 MHz, CDCl3) δ 154.5, 152.8, 135.8, 131.3, 129.2, 123.1, 
122.1, 84.2, 25.1. 
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(E)-1-Phenyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)diazene (S4)  
was prepared analogously to S2: Reaction of aniline S3 (1.10 g, 5.00 mmol, 1 eq.) with 
nitrosobenzene (803 mg, 7.50 mmol, 1.5 eq.) gave S4 as a red oil that crystallized upon standing 
in the freezer (810 mg, 2.63 mmol, 53%). 
TLC: Rf = 0.76 (DCM/P 7:3). Mp: 108 – 112 °C. 
1
H NMR (400 MHz, CDCl3): δ 8.37 (s, 1H), 
8.02 (ddd, J = 8.0, 2.2, 1.3 Hz, 1H), 7.97 – 7.91 (m, 3H), 7.56 – 7.45 (m, 4H), 1.39 (s, 12H). 
13
C NMR (101 MHz, CDCl3): δ 152.8, 152.2, 137.4, 131.0, 129.4, 129.2, 128.7, 125.5, 123.0, 






Initially following a previously reported procedure for the synthesis of azobenzene S6,
2
 
4-bromoaniline (S5, 1.72 g, 10.0 mmol, 1 eq.) was dissolved in 13 mL 2 N aqueous HCl and 
cooled to 0 °C before a solution of NaNO2 (690 mg, 10.0 mmol, 1 eq.) in 10 mL water was added 
dropwise from a dropping funnel. In a separate flask, phenol (941 mg, 10.0 mmol, 1 eq.) 
dissolved in 200 mL of water was treated with NaOH (400 mg, 10.0 mmol, 1 eq.) and Na2CO3 
(2.12 g, 20.0 mmol, 2 eq.) and the resulting solution was cooled to 0 °C. To this, the diazonium 
solution was carefully added via dropping funnel, and upon complete addition stirring at 0 °C 
was continued for 30 min. After acidifying the reaction mixture with 2 N aqueous HCl, the 
orange precipitate was filtered off, washed with water and dried in vacuo. The thus obtained 
crude azobenzene S6 was dissolved in acetone, and iodomethane (0.93 mL, 2.13 g, 15.0 mmol, 
1.5 eq.) and K2CO3 (2.07 g, 15 mmol, 1.5 eq.) were added to the solution. The reaction mixture 
was stirred at 40 °C for 18 h, before the solvent was removed under reduced pressure and the 
residue was partitioned between DCM and water (60 mL each). The aqueous layer was extracted 
with DCM (1 × 60 mL), the combined organic layers were washed with brine, dried over Na2SO4 
and concentrated under reduced pressure. Purification by flash chromatography (P/EtOAc 100:0 
→ 99:1 → 98:2 → 95:5) yielded azobenzene S7 as an orange solid (1.87 g, 6.42 mmol, 64% over 
two stpes). 
TLC: Rf = 0.59 (P/EtOAc 95:5). 
1
H NMR (400 MHz, CDCl3): δ 7.92 (d, J = 9.0 Hz, 2H), 7.76 
(d, J = 8.6 Hz, 2H), 7.63 (d, J = 8.7 Hz, 2H), 7.02 (d, J = 9.0 Hz, 2H), 3.90 (s, 3H). 
13
C NMR 
(101 MHz, CDCl3): δ 162.5, 151.6, 147.0, 132.4, 125.1, 124.7, 124.2, 114.4, 55.8. 
The spectroscopic data is in accordance with the literature.
3
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A suspension of bromide S7 (349 mg, 1.20 mmol, 1 eq.), bis(pinacolato)diboron (335 mg, 
1.32 mmol, 1.1 eq.) and KOAc (353 mg, 3.60 mmol, 3 eq.) in 2.5 mL dry DMSO was purged 
with argon for 1 h, before Pd(dppf)Cl2 (43.0 mg, 60.0 μmol, 5 mol%) was added and the resulting 
reaction mixture stirred at 80 °C for 17 h. Having cooled to room temperature, the reaction 
mixture was partitioned between EtOAc and diluted aqueous NaHCO3 solution (30 mL each). 
The aqueous layer was extracted with EtOAc (1 × 30 mL), the combined organic layers were 
washed with brine, dried over Na2SO4 and concentrated under reduced pressure. Purification by 
flash chromatography (P/EtOAc 95:5 → 90:10) gave boronic ester S8 as a red-orange solid 
(271 mg, 0.801 mmol, 67%) 
TLC: Rf = 0.38 (P/EtOAc 9:1). Mp: 122 – 125 °C. 
1
H NMR (400 MHz, CDCl3): δ 7.97 – 7.91 
(m, 4H), 7.88 – 7.84 (m, 2H), 7.04 – 6.99 (m, 2H), 3.90 (s, 3H), 1.37 (s, 12H). 13C NMR (101 
MHz, CDCl3): δ 162.4, 154.6, 147.2, 135.8, 125.1, 121.9, 114.4, 84.2, 55.7, 25.1. HRMS (ESI): 






Scheme S2  Synthesis of diaminopyrimidines S12-14. 
5-(4-Bromo-3,5-dimethoxybenzyl)pyrimidine-2,4-diamine (S12): 
Following a previously reported, modified procedure,
4
 3-anilinopropionitrile (1.61 g, 11.0 mmol, 
1.1 eq.) and subsequently KOt-Bu (1.29 g, 11.5 mmol, 1.15 eq.) were added to a solution of 
4-bromo-3,5-benzaldehyde (S9, 2.45 g, 10.0 mmol, 1 eq.) in 25 mL dry DMSO. The reaction 
mixture was stirred at room temperature for 1 h and then partitioned between EtOAc and water 
(250 mL each). The aqueous layer was extracted with EtOAc (2 × 100 mL) and the combined 
organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced 
pressure. A guanidine solution was prepared separately by dissolving guanidine hydrochloride 
                                                 
4
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(2.87 g, 30.0 mmol, 3 eq.) in 30 mL dry EtOH under nitrogen atmosphere and treating it with 
KOt-Bu (3.37 g, 30.0 mmol, 3 eq.). This mixture was allowed to stir for 30 min at room 
temperature, before it was filtered over a glass filter and the filter cake washed with another 
30 mL of EtOH. The obtained filtrate was then added to the crude intermediate of the first step 
under nitrogen and stirred under reflux for 16 h. Upon cooling, the product crystallized from the 
reaction mixture. It was filtered off, washed successively with ice-cooled water and water/EtOH 
(1:1) and dried in vacuo, after which diaminopyrimidine S12 was obtained as a yellow powder 
(1.92 g, 5.66 mmol, 57% over two steps). 
1
H NMR (400 MHz, DMSO-d6): δ 7.54 (s, 1H), 6.64 (s, 2H), 6.11 (bs, 2H), 5.70 (bs, 2H), 3.78 
(s, 6H), 3.58 (s, 2H). 
13
C NMR (101 MHz, DMSO-d6): δ 162.3, 162.2, 156.3, 155.8, 141.6, 
105.4, 105.3, 97.1, 56.2, 33.1. 
The spectroscopic data is in accordance with the literature.
5
 
5-(3-Bromo-4,5-dimethoxybenzyl)pyrimidine-2,4-diamine (S13)  
was prepared analogously to S12: Reacting 3-bromo-4,5-dimethoxybenzaldehyde (S10, 2.00 g, 
8.16 mmol, 1 eq.) following the two-step procedure gave diaminopyrimidine S13 as a yellow 
crystalline solid (1.72 g, 5.07 mmol, 62% over two steps). 
Mp: 203 – 205 °C. 1H NMR (400 MHz, DMSO-d6): δ 7.58 (s, 1H), 7.00 – 6.95 (m, 2H), 6.16 
(bs, 2H), 5.77 (bs, 2H), 3.79 (s, 3H), 3.69 (s, 3H), 3.56 (s, 2H).
 13
C NMR (101 MHz, DMSO-d6): 
δ 162.4, 162.1, 156.1, 153.1, 143.8, 138.2, 123.4, 116.3, 112.9, 105.2, 60.0, 56.0, 32.0. HRMS 





5-(2-Bromo-3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine (S14)  
was prepared analogously to S12: Reacting 2-bromo-3,4,5-trimethoxybenzaldehyde
6
 (S11, 
2.50 g, 9.09 mmol, 1 eq.) following the two-step procedure gave diaminopyrimidine S14 as an 
off-white solid (1.71 g, 4.63 mmol, 51% over two steps). 
Mp: 194 – 196 °C. 1H NMR (400 MHz, DMSO-d6): δ 7.12 (s, 1H), 6.76 (s, 1H), 6.24 (bs, 2H), 
5.75 (bs, 2H), 3.78 (s, 3H), 3.76 (s, 3H), 3.73 (s, 3H), 3.61 (s, 2H). 
13
C NMR (101 MHz, 
DMSO-d6): δ 162.3, 162.2, 155.0, 152.4, 150.3, 141.1, 134.2, 110.2, 110.1, 103.6, 60.7, 60.7, 





                                                 
5
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All solvents were separately purged with argon before use. Bromide S12 (321 mg, 0.947 mmol, 
1 eq.) was added to a suspension of Pd(PPh3)4 (55.0 mg, 47.4 μmol, 5 mol%) in 7.3 mL 
1,2-dimethoxyethane under nitrogen atmosphere and the resulting mixture stirred for 15 min at 
room temperature. Subsequently, boronic ester S2 (321 mg, 1.04 mmol, 1.1 eq.) dissolved in 
1 mL THF was added to the reaction mixture (an additional 1 mL THF was used to rinse the 
boronic ester vessel), followed by the addition of 4 mL of a 2 N aqueous K2CO3 solution (1.11 g, 
8.05 mmol, 8.5 eq.). The biphasic reaction mixture was then vigorously stirred at 85 °C for 44 h. 
After cooling to room temperature, the mixture was partitioned between water and EtOAc, the 
separated aqueous layer extracted with EtOAc (2 × 20 mL), and the combined organic layers 
were washed with brine, dried over Na2SO4 and concentrated under reduced pressure. After 
purification by flash chromatography (DCM/MeOH 98:2 → 95:5), diaminopyrimidine 2a was 
obtained as an orange powder (206 mg, 0.468 mmol, 48%). 
TLC: Rf = 0.45 (DCM/MeOH 8:1). Mp: 232 – 234 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.93 – 
7.83 (m, 4H), 7.65 – 7.52 (m, 4H), 7.48 – 7.40 (m, 2H), 6.69 (s, 2H), 6.16 (bs, 2H), 5.72 (bs, 2H), 
3.68 – 3.63 (m, 8H). 13C NMR (101 MHz, DMSO-d6): δ 162.3, 162.2, 156.8, 155.8, 152.1, 150.4, 
142.3, 137.9, 132.0, 131.3, 129.4, 122.5, 121.7, 115.3, 105.5, 104.8, 55.7, 33.3. HRMS (ESI): 










In a procedure analogous to the preparation of 2a, coupling of bromide S12 (236 mg, 
0.696 mmol, 1 eq.) with boronic ester S8 (259 mg, 0.766 mmol, 1.1 eq.) for 48 h gave 
diaminopyrimidine 2b as a bright orange solid (213 mg, 0.453 mmol, 65%). 
TLC: Rf = 0.42 (DCM/MeOH 8:1). Mp: 244 – 246 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.92 – 
7.87 (m, 2H), 7.84 – 7.79 (m, 2H), 7.61 (s, 1H), 7.42 – 7.38 (m, 2H), 7.17 – 7.11 (m, 2H), 6.69 (s, 
2H), 6.15 (bs, 2H), 5.70 (bs, 2H), 3.87 (s, 3H), 3.65 (s, 6H), 3.64 (s, 2H). 
13
C NMR (101 MHz, 
DMSO-d6): δ 162.3, 162.2, 161.9, 156.9, 155.9, 150.5, 146.3, 142.2, 137.1, 131.9, 124.5, 121.4, 









In a procedure analogous to the preparation of 2a, coupling of bromide S12 (339 mg, 1.00 mmol, 
1 eq.) with boronic ester S4 (339 mg, 1.10 mmol, 1.1 eq.) for 48 h gave diaminopyrimidine 2c as 
an orange crystalline solid (92.5 mg, 0.210 mmol, 21%). 
TLC: Rf = 0.46 (DCM/MeOH 8:1). Mp: 218 – 220 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.91 – 
7.86 (m, 2H), 7.82 – 7.77 (m, 1H), 7.72 – 7.70 (m, 1H), 7.62 (s, 1H), 7.61 – 7.53 (m, 4H), 7.39 
(d, J = 7.5 Hz, 1H), 6.70 (s, 2H), 6.19 (bs, 2H), 5.75 (bs, 2H), 3.67 – 3.63 (m, 8H). 13C NMR 
(101 MHz, DMSO-d6): δ 162.3, 162.2, 156.9, 155.7, 151.9, 151.6, 142.1, 135.6, 134.1, 131.4, 
129.4, 128.6, 125.0, 122.5, 120.7, 115.3, 105.6, 104.8, 55.7, 33.3. HRMS (ESI): m/z 441.2033 









In a procedure analogous to the preparation of 2a, coupling of bromide S13 (339 mg, 1.00 mmol, 
1 eq.) with boronic ester S2 (339 mg, 1.10 mmol, 1.1 eq.) for 60 h gave diaminopyrimidine 2d as 
a red crystalline solid (426 mg, 0.967 mmol, 97%). 
TLC: Rf = 0.37 (DCM/MeOH 8:1). Mp: 98 – 101 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.95 
(d, J = 8.3 Hz, 2H), 7.93 – 7.89 (m, 2H), 7.67 (d, J = 8.4 Hz, 2H), 7.64 – 7.55 (m, 4H), 7.02 (d, J 
= 1.9 Hz, 1H), 6.88 (d, J = 1.9 Hz, 1H), 6.16 (bs, 2H), 5.72 (bs, 2H), 3.83 (s, 3H), 3.63 (s, 2H), 
3.55 (s, 3H). 
13
C NMR (101 MHz, DMSO-d6): δ 162.2, 162.2, 155.7, 152.5, 152.0, 150.7, 144.2, 
141.2, 136.5, 133.4, 131.5, 130.0, 129.5, 122.5, 122.4, 121.6, 113.2, 105.7, 60.2, 55.8, 32.4. 








In a procedure analogous to the preparation of 2a, coupling of bromide S13 (339 mg, 1.00 mmol, 
1 eq.) with boronic ester S4 (339 mg, 1.10 mmol, 1.1 eq.) gave diaminopyrimidine 2e as an 
orange foam (320 mg, 0.726 mmol, 73%). 
TLC: Rf = 0.55 (DCM/MeOH 8:1). Mp: 98 – 101 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.95 (s, 
1H), 7.94 – 7.85 (m, 3H), 7.67 – 7.55 (m, 6H), 7.02 (d, J = 1.9 Hz, 1H), 6.90 (d, J = 1.9 Hz, 1H), 
6.19 (bs, 2H), 5.74 (bs, 2H), 3.83 (s, 3H), 3.62 (s, 2H), 3.55 (s, 3H). 
13
C NMR (101 MHz, 
DMSO-d6): δ 162.2, 162.2, 155.7, 152.5, 151.9, 151.8, 144.1, 139.2, 136.5, 133.5, 132.0, 131.6, 
129.5, 129.3, 123.1, 122.6, 121.7, 121.1, 113.0, 105.7, 60.2, 55.8, 32.4. HRMS (ESI): m/z 









In a procedure analogous to the preparation of 2a, coupling of bromide S14 (369 mg, 1.00 mmol, 
1 eq.) with boronic ester S2 (339 mg, 1.10 mmol, 1.1 eq.) gave diaminopyrimidine 2f as a red-
orange foam (348 mg, 0.740 mmol, 74%). 
TLC: Rf = 0.58 (DCM/MeOH 8:1). Mp: 56 – 59 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.94 – 
7.85 (m, 4H), 7.64 – 7.55 (m, 3H), 7.39 (d, J = 8.1 Hz, 2H), 6.98 (s, 1H), 6.72 (s, 1H), 6.00 (bs, 
2H), 5.66 (bs, 2H), 3.79 (s, 3H), 3.78 (s, 3H), 3.55 (s, 3H), 3.34 (s, 2H).
 13
C NMR (101 MHz, 
DMSO-d6): δ 162.0, 161.9, 154.9, 152.6, 152.0, 150.8, 150.6, 140.2, 140.2, 132.6, 131.4, 131.1, 
129.5, 127.7, 122.5, 122.1, 109.3, 105.1, 60.7, 60.4, 55.9, 30.9. HRMS (ESI): m/z 471.2138 











2-Bromoacetyl bromide (0.5 mL, 1.16 g, 5.74 mmol, 1 eq.) was added dropwise over 30 min to a 
solution of 4-aminoazobenzene (S15, 1.25 g, 6.31 mmol, 1.1 eq.) in 50 mL dry benzene, and the 
resulting reaction mixture was stirred under reflux for 24 h. After cooling to room temperature, 
the newly formed brownish precipitate was filtered off and recrystallized from EtOH to give 
acylated aminoazobenzene S16 as a red crystalline solid (816 mg, 2.56 mmol, 45%). 
1
H NMR (400 MHz, DMSO-d6): δ 10.76 (s, 1H), 7.94 – 7.89 (m, 2H), 7.89 – 7.79 (m, 4H), 7.62 
– 7.50 (m, 3H), 4.10 (s, 2H). 
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Nitrosobenzene (0.957 g, 8.93 mmol, 1.1 eq.) was added to a solution of 3-aminobenzyl alcohol 
(S17, 1.00 g, 8.12 mmol, 1 eq.) in 40 mL glacial acetic acid under nitrogen atmosphere, and the 
reaction mixture was stirred at room temperature. After 15 h, acetic acid was removed under 
reduced pressure, the residue was taken up in EtOAc and washed with water. The aqueous layer 
was extracted with EtOAc (2 × 30 mL) and the combined organic layers were successively 
washed with saturated, aqueous NaHCO3 solution, water and brine, and dried over Na2SO4. After 
purification by flash chromatography (P/EtOAc 90:10 → 80:10 → 70:30), azobenzene S18 was 
obtained as a red oil that crystallized upon standing in the fridge (1.50 g, 7.07 mmol, 87%). 
TLC: Rf = 0.57 (P/EtOAc 7:3). 
1
H NMR (400 MHz, CDCl3): δ 7.96 – 7.89 (m, 3H), 7.89 – 7.81 
(m, 1H), 7.56 – 7.44 (m, 5H), 4.79 (s, 2H), 2.07 (s, 1H). 






A solution of alcohol S18 (1.47 g, 6.92 mmol, 1 eq.) in 35 mL dry THF under nitrogen 
atmosphere was cooled to 0 °C and alternatingly treated with portions of N-bromosuccinimide 
(1.85 g, 10.4 mmol, 1.5 eq.) and triphenylphosphine (2.73 g, 10.4 mmol, 1.5 eq.). The reaction 
mixture was stirred at room temperature for 20 h, before it was filtered over a short plug of silica 
and the filtrate was concentrated under reduced pressure. Purification of the residue by flash 
chromatography (P/EtOAc 99:1 → 98:2), gave bromide S19 as a red oil that crystallized upon 
standing in the fridge (1.82 g, 6.61 mmol, 96%). 
TLC: Rf = 0.75 (P/EtOAc 8:2). 
1
H NMR (400 MHz, CDCl3): δ 7.98 – 7.91 (m, 3H), 7.93 – 7.83 
(m, 1H), 7.58 – 7.47 (m, 5H), 4.59 (s, 2H). 13C NMR (101 MHz, CDCl3): δ 153.0, 152.7, 139.0, 
131.5, 131.4, 129.7, 129.3, 123.5, 123.1, 123.0, 32.9. 
The spectroscopic data is in accordance with the literature.
9
 
(E)-1-(4-(Bromomethyl)phenyl)-2-phenyldiazene (S22)  
was prepared analogously to S19 in a two-step procedure starting from 4-aminobenzyl alcohol 
(S20, 1.23 g, 10.0 mmol, 1 eq.) via azobenzene S21, bromination of which yielded S22 as an 
orange solid (1.04 g, 3.78 mmol, 38% over two steps). 
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TLC: Rf = 0.72 (P/EtOAc 9:1). 
1
H NMR (400 MHz, CDCl3): δ 7.96 – 7.86 (m, 4H), 7.57 – 7.46 
(m, 5H), 4.56 (s, 2H). 
13
C NMR (101 MHz, CDCl3): δ 152.7, 152.5, 140.7, 131.4, 130.0, 129.3, 
123.4, 123.1, 32.9. 






A suspension of 4-aminobenzyl alcohol (S20, 2.00 g, 16.2 mmol, 1 eq.) in 30 mL water at 0 °C 
was treated with 3.4 mL concentrated aqueous HCl, followed by the slow addition of an ice-
cooled solution of NaNO2 (1.17 g, 17.0 mmol, 1.05 eq.) in 8 mL water. After 1 h of stirring under 
continued cooling, a separately prepared solution of phenol (1.60 g, 17.0 mmol, 1.05 eq.) and 
K2CO3 (3.14 g, 22.7 mmol, 1.4 eq.) in 25 mL water was added dropwise over 10 min, after which 
stirring was continued for a further 1.5 h. Diluted aqueous acetic acid was then used to acidify the 
reaction mixture to a pH of 4-5, before the obtained precipitate was filtered off and washed with 
water and small amounts of MeOH. Drying in vacuo gave azobenzene S23 as a yellow solid 
(2.63 g, 11.5 mmol, 71%).  
1
H NMR (400 MHz, DMSO-d6): δ 10.25 (bs, 1H), 7.83 – 7.76 (m, 4H), 7.49 (d, J = 8.2 Hz, 2H), 
6.98 – 6.91 (m, 2H), 5.34 b(s, 1H), 4.59 (s, 2H). 13C NMR (101 MHz, DMSO-d6): δ 160.8, 
151.0, 145.2, 145.2, 127.1, 124.7, 121.9, 115.9, 62.5. 






Iodomethane (0.53 mL, 1.21 g, 8.54 mmol, 1.5 eq.) and K2CO3 (1.18 g, 8.54 mmol, 1.5 eq.) were 
added to a solution of azobenzene S23 (1.30 g, 5.70 mmol, 1 eq.) in 100 mL acetone. The 
reaction mixture was stirred at 40 °C for 20 h, before the solvent was removed under reduced 
pressure and the residue partitioned between DCM and water (100 mL each). The aqueous layer 
was extracted with DCM (2 × 80 mL), the combined organic layers were dried over Na2SO4 and 
concentrated under reduced pressure. Purification by flash chromatography (P/EtOAc 70:30 → 
60:40) yielded azobenzene S24 as an orange crystalline solid (1.27 g, 5.24 mmol, 92%). 
TLC: Rf = 0.60 (P/EtOAc 6:4). 
1
H NMR (400 MHz, DMSO-d6): δ 7.89 (d, J = 8.9 Hz, 2H), 7.82 
(d, J = 8.2 Hz, 2H), 7.51 (d, J = 8.2 Hz, 2H), 7.12 (d, J = 9.0 Hz, 2H), 5.37 (t, J = 5.7 Hz, 1H), 
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4.60 (d, J = 5.5 Hz, 2H), 3.85 (s, 3H). 
13
C NMR (101 MHz, DMSO-d6): δ 161.9, 150.9, 146.2, 
145.7, 127.1, 124.5, 122.1, 114.6, 62.5, 55.6. 
The spectroscopic data is in accordance with the literature.
11
 
(E)-1-(4-(Bromomethyl)phenyl)-2-(4-methoxyphenyl)diazene (S25)  
was prepared analogously to S19: Reaction of alcohol S24 (1.28 g, 5.30 mmol, 1 eq.) with 
N-bromosuccinimide and triphenylphosphine gave bromide S25 as an orange solid (1.56 g, 
5.11 mmol, 96%). 
TLC: Rf = 0.59 (P/EtOAc 6:4). Mp: 114 – 117 °C.  
1
H NMR (400 MHz, CDCl3): δ 7.93 (d, J = 
8.9 Hz, 2H), 7.86 (d, J = 8.4 Hz, 2H), 7.52 (d, J = 8.4 Hz, 2H), 7.02 (d, J = 9.0 Hz, 2H), 4.56 (s, 
2H), 3.90 (s, 3H). 
13
C NMR (101 MHz, CDCl3): δ 162.4, 152.6, 147.1, 139.9, 130.0, 125.0, 











Trimethoprim (10.0 g, 34.4 mmol) was dissolved in 120 mL 48% aqueous HBr preheated to 
90 °C. The resulting solution was stirred at 100 °C for 30 min and subsequently quenched by 
careful addition of 25 mL 50% aqueous NaOH. After standing overnight in the fridge, the formed 
crystals were filtered off, washed with ice-cooled water and then dissolved in boiling water. The 
hot solution was neutralized with 25% aqueous ammonia, upon which the product recrystallized. 
After standing in the fridge for another night, the crystals were filtered off and dried in vacuo, 
resulting in phenol 11 as an off-white crystalline solid (6.24 g, 22.6 mmol, 66%). 
1
H NMR (400 MHz, DMSO-d6): δ 8.16 (bs, 1H), 7.46 (s, 1H), 6.49 (s, 2H), 6.08 (bs, 2H), 5.71 
(bs, 2H), 3.70 (s, 6H), 3.47 (s, 2H).  
The spectroscopic data is in accordance with the literature.
13
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Following a modified procedure previously reported for the preparation of a different product,
12
 
KOt-Bu (15.6 mg, 0.139 mmol, 1.1 eq.) was added to a solution of phenol 11 (34.8 mg, 
0.126 mmol, 1 eq.) in 0.83 mL dry DMSO under nitrogen atmosphere and the resulting mixture 
stirred for 30 min at room temperature. Subsequently bromide S16 (44.1 mg, 0.139 mmol, 
1.1 eq.) was added to the reaction, and stirring at room temperature was continued for 4 h. The 
reaction mixture was then partitioned between water and EtOAc, the separated aqueous layer was 
extracted with EtOAc (3 × 20 mL), and the combined organic layers were washed with brine, 
dried over Na2SO4 and concentrated under reduced pressure. After purification by flash 
chromatography (DCM/MeOH 95:5 → 90:10), diaminopyrimidine 2j was obtained as an orange 
solid (26.2 mg, 51.0 μmol, 40%). 
TLC: Rf = 0.53 (DCM/MeOH 6:1). Mp: 211 – 214 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 10.17 
(s, 1H), 7.96 – 7.83 (m, 6H), 7.62 – 7.52 (m, 3H), 7.49 (s, 1H), 6.67 (s, 2H), 6.57 (bs, 2H), 6.37 
(bs, 2H), 4.53 (s, 2H), 3.81 (s, 6H), 3.57 (s, 2H). 
13
C NMR (101 MHz, DMSO-d6): δ 167.9, 
162.6, 160.4, 152.0, 151.9, 151.7, 147.9, 141.1, 136.0, 134.4, 131.1, 129.4, 123.7, 122.4, 119.7, 








In a procedure analogous to the preparation of 2j, reaction of phenol 1 (111 mg, 0.400 mmol, 
1 eq.) with bromide S19 (121 mg, 0.440 mmol, 1.1 eq.) and purification by flash chromatography 
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(DCM/MeOH 98:2 → 95:5) gave diaminopyrimidine 2g as a red-orange crystalline solid 
(140 mg, 0.298 mmol, 75%). 
TLC: Rf = 0.37 (DCM/MeOH 8:1). Mp: 161 – 163 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 8.03 
(s, 1H), 7.92 (d, J = 7.4 Hz, 2H), 7.86 (d, J = 7.5 Hz, 1H), 7.66 – 7.55 (m, 5H), 7.52 (s, 1H), 6.59 
(s, 2H), 6.10 (bs, 2H), 5.70 (bs, 2H), 4.98 (s, 2H), 3.75 (s, 6H), 3.54 (s, 2H). 
13
C NMR (101 
MHz, DMSO-d6): δ 162.2, 162.2, 155.6, 152.8, 151.9, 151.8, 139.7, 136.2, 134.5, 131.5, 130.6, 
129.5, 129.2, 122.7, 122.5, 120.9, 105.8, 105.8, 73.5, 55.9, 33.0. HRMS (ESI): m/z 471.2141 







In a procedure analogous to the preparation of 2j, reaction of phenol 11 (111 mg, 0.400 mmol, 
1 eq.) with bromide S22 (121 mg, 0.440 mmol, 1.1 eq.) and purification by flash chromatography 
(DCM/MeOH 98:2 → 95:5) gave diaminopyrimidine 2h as an orange solid (105 mg, 
0.223 mmol, 56%). 
TLC: Rf = 0.36 (DCM/MeOH 8:1). Mp: 204 – 206 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.93 – 
7.87 (m, 4H), 7.67 (d, J = 8.3 Hz, 2H), 7.64 – 7.56 (m, 3H), 7.53 (s, 1H), 6.60 (s, 2H), 6.11 (bs, 
2H), 5.71 (bs, 2H), 4.96 (s, 2H), 3.75 (s, 6H), 3.55 (s, 2H).
 13
C NMR (101 MHz, DMSO-d6): δ 
162.2, 162.2, 155.5, 152.8, 151.9, 151.3, 141.7, 136.2, 134.5, 131.5, 129.5, 128.6, 122.5, 122.4, 










In a procedure analogous to the preparation of 2j, reaction of phenol 11 (100 mg, 0.362 mmol, 
1 eq.) with bromide S25 (121 mg, 0.398 mmol, 1.1 eq.) and purification by flash chromatography 
(DCM/MeOH 98:2 → 95:5) gave diaminopyrimidine 2i as an orange solid (66.6 mg, 
0.133 mmol, 37%). 
TLC: Rf = 0.47 (DCM/MeOH 8:1). Mp: 209 – 211 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.90 
(d, J = 8.9 Hz, 2H), 7.84 (d, J = 8.1 Hz, 2H), 7.64 (d, J = 8.1 Hz, 2H), 7.53 (s, 1H), 7.14 (d, J = 
9.0 Hz, 2H), 6.59 (s, 2H), 6.15 (bs, 2H), 5.75 (bs, 2H), 4.94 (s, 2H), 3.87 (s, 3H), 3.75 (s, 6H), 
3.55 (s, 2H). 
13
C NMR (101 MHz, DMSO-d6): δ 162.2, 162.0, 162.0, 155.2, 152.8, 151.4, 146.2, 
140.9, 136.1, 134.5, 128.6, 124.5, 122.0, 114.6, 105.8, 105.8, 73.5, 55.9, 55.6, 33.0. HRMS 






Synthesis of red-shifted diaminopyrimidines 12 and 13 
 
Scheme S6  Synthesis of diaminopyrimidines 12 and 13. 
(Z)-1-(2,6-Difluoro-4-methylphenyl)-2-(2,6-difluorophenyl)diazene (7): 
Following our previously reported procedure in a slightly modified way,
14
 3,5-difluorotoluene 
(512 mg, 4.00 mmol, 1 eq.) dissolved in 8 mL dry THF at -78 °C was slowly treated with a 
solution of n-BuLi (1.6 M in hexane, 2.5 mL, 4.00 mmol, 1 eq.), after which stirring was 
continued at -78 °C for 1 h. Solid 2,6-difluorobenzenediazonium tetrafluoroborate
14
 (5, 912 mg, 
4.00 mmol, 1 eq.) was then at once added to the reaction mixture, which was subsequently 
allowed to warm to room temperature over 1.5 h. The reaction was quenched with saturated 
aqueous NaHCO3 solution, extracted with EtOAc (3 × 20 mL), and the combined organic layers 
were washed with brine, dried over Na2SO4 and concentrated under reduced pressure. After 
purification by flash chromatography (P/EtOAc 100:0 → 99:1 → 98:2), azobenzene 7 was 
obtained as a dark-red crystalline solid (766 mg, 2.86 mmol, 72%) consisting mainly of the cis 
isomer, which was used in the next step without thermal adaptation. 
TLC: Rf = 0.38 (P/EtOAc 95:5). Mp: 85 – 87 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.65 – 7.54 
(m, 1H), 7.35 (t, J = 9.6 Hz, 2H), 7.22 (d, J = 11.6 Hz, 2H), 2.41 (s, 3H).
 13
C NMR (101 MHz, 
DMSO-d6): δ 159.0 (dd, J = 7.7, 4.7 Hz), 156.4 (dd, J = 6.8, 4.6 Hz), 148.38 (t, J = 10.6 Hz), 
135.8 (t, J = 10.6 Hz), 133.9 (t, J = 10.3 Hz), 131.5 (t, J = 9.7 Hz), 116.7 (dd, J = 20.0, 3.2 Hz), 
116.3 (dd, J = 20.6, 2.9 Hz), 24.3. 
19
F NMR (376 MHz, DMSO-d6): δ -122.0 (d, J = 10.8 
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(Z)-1-(2,6-Ddichloro-4-methylphenyl)-2-(2,6-dichlorophenyl)diazene (8): 
In a procedure analogous to the preparation of 7, reaction of 3,5-dichlorotoluene (593 mg, 
3.68 mmol, 1 eq.) with n-BuLi and 2,6-dichlorobenzenediazonium tetrafluoroborate
14
 (6, 961 mg, 
3.68 mmol, 1 eq.) gave azobenzene 8 as a dark-red crystalline solid (916 mg, 2.74 mmol, 75%) 
consisting mainly of the cis isomer, which was used in the next step without thermal adaptation. 
TLC: Rf = 0.55 (P/EtOAc 95:5). Mp: 121 – 124 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.69 (d, J 
= 8.1 Hz, 2H), 7.55 (s, 2H), 7.50 (t, J = 8.1 Hz, 1H), 2.39 (s, 3H). 
13
C NMR (101 MHz, 
DMSO-d6): δ 146.8, 143.9, 142.4, 130.9, 130.3, 129.8, 126.2, 125.8, 20.2. HRMS (ESI): m/z 








Azobenzene 7 (268 mg, 1.00 mmol, 1 eq.), N-bromosuccinimide (178 mg, 1.00 mmol, 1 eq.) and 
AIBN (33.0 mg, 0.200 mmol, 20 mol%) were dissolved in 10 mL carbon tetrachloride under 
nitrogen atmosphere. The resulting mixture was heated to 85 °C with stirring for 60 h. After 
cooling to room temperature, the solvent was then removed under reduced pressure and the 
product purified by flash chromatography (P/EtOAc 98:2 → 96:4) to yield bromide 9 as a dark 
red solid (166 mg, 0.478 mmol, 48%). KOt-Bu (49.3 mg, 0.440 mmol, 1.1 eq.) was added to a 
solution of phenol 11 (111 mg, 0.400 mmol, 1 eq.) in 1.3 mL dry DMSO under nitrogen 
atmosphere and the resulting mixture was stirred for 30 min at room temperature. Subsequently 
bromide 9 (153 mg, 0.440 mmol, 1.1 eq.) was added to the reaction, and stirring at room 
temperature was continued for 4 h. The reaction mixture was then partitioned between water and 
EtOAc, the separated aqueous layer was extracted with EtOAc (3 × 30 mL), and the combined 
organic layers were washed with brine, dried over Na2SO4 and concentrated under reduced 
pressure. After purification by flash chromatography (DCM/MeOH 98:2 → 95:5), 
diaminopyrimidine 12 was obtained as a red-orange crystalline solid (207 mg, 0.382 mmol, 
95%). 
S19
TLC: Rf = 0.36 (DCM/MeOH 8:1). Mp: 183 – 185 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.63 
(tt, J = 8.4, 6.1 Hz, 1H), 7.53 (s, 1H), 7.46 (d, J = 10.9 Hz, 2H), 7.37 (t, J = 9.3 Hz, 2H), 6.61 (s, 
2H), 6.12 (bs, 2H), 5.71 (bs, 2H), 4.99 (s, 2H), 3.76 (s, 6H), 3.55 (s, 2H). 
13
C NMR (101 MHz, 
DMSO-d6): δ 162.2, 162.1, 155.9 (dd, J = 10.8, 4.3 Hz), 155.5, 153.3 (dd, J = 11.2, 4.4 Hz), 
152.5, 145.1 (t, J = 9.9 Hz), 136.5, 134.3, 133.1 (t, J = 10.8 Hz), 130.7 (t, J = 10.0 Hz), 129.5 (t, J 
= 10.1 Hz), 113.2 (dd, J = 20.1, 3.4 Hz), 111.3 (dd, J = 21.1, 3.2 Hz), 105.7, 105.7, 72.5, 55.9, 
33.0. 
19
F NMR (376 MHz, DMSO-d6): δ -121.4 (d, J = 10.8 Hz), -122.0 (dd, J = 10.0, 6.1 Hz). 








In a two-step procedure analogous to the preparation of 12, reacting azobenzene 8 (305 mg, 
0.913 mmol, 1 eq.) with N-bromosuccinimide (162 mg, 0.913 mmol, 1 eq.) and AIBN (16.0 mg, 
45.7 μmol, 10 mol%) at 85 °C for 22 h first gave bromide 10 as a dark red solid (198 mg, 
0.480 mmol, 53%). Bromide 10 (182 mg, 0.440 mmol, 1.1 eq.) was subsequently reacted with 
phenol 11 (111 mg, 0.400 mmol, 1 eq.) and KOt-Bu, after which purification by flash 
chromatography (DCM/MeOH 98:2 → 95:5) gave diaminopyrimidine 13 as an reddish brown 
solid (159 mg, 0.261 mmol, 65%). 
TLC: Rf = 0.43 (DCM/MeOH 8:1). Mp: 215 – 217 °C. 
1
H NMR (400 MHz, DMSO-d6): δ 7.80 
(s, 2H), 7.72 (d, J = 8.1 Hz, 2H), 7.56 – 7.49 (m, 2H), 6.61 (s, 2H), 6.13 (bs, 2H), 5.72 (bs, 2H), 
4.99 (s, 2H), 3.76 (s, 6H), 3.54 (s, 2H). 
13
C NMR (101 MHz, DMSO-d6): δ 162.2, 162.2, 155.7, 
152.5, 146.6, 145.3, 142.4, 136.5, 134.2, 131.2, 129.9, 128.4, 126.0, 125.9, 105.7, 105.7, 72.2, 






Photoisomerization of diaminopyrimidines 2a-2j 
             
 
Figure S1  Photochemistry of compound 2a in DMSO: A) Extract from 
1
H NMR spectra before and after irradiation 
with UV light at λ = 365 nm (c ≈ 2 mM). B) UV-Vis absorption spectra before and after irradiation with UV light at 
λ = 365 nm (c ≈ 30 μM). C) Reversible photochromism. D) Thermal cis-trans isomerization at 37 °C. 
    
 
Figure S2  Photochemistry of compound 2b in DMSO: A) Extract from 
1
H NMR spectra before and after irradiation 
with UV light at λ = 365 nm (c ≈ 2 mM). B) UV-Vis absorption spectra before and after irradiation with UV light at 
λ = 365 nm (c ≈ 30 μM). C) Reversible photochromism. D) Thermal cis-trans isomerization at 37 °C. 
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Figure S3  Photochemistry of compound 2c in DMSO: A) Extract from 
1
H NMR spectra before and after irradiation 
with UV light at λ = 365 nm (c ≈ 2 mM). B) UV-Vis absorption spectra before and after irradiation with UV light at 
λ = 365 nm (c ≈ 30 μM). C) Reversible photochromism. D) Thermal cis-trans isomerization at 37 °C. 
         
 
Figure S4  Photochemistry of compound 2d in DMSO: A) Extract from 
1
H NMR spectra before and after irradiation 
with UV light at λ = 365 nm (c ≈ 2 mM). B) UV-Vis absorption spectra before and after irradiation with UV light at 



















irradiation with                365 nm               white light





















t1/2 > 16 h















 irradiated with 365 nm
B C D








































irradiation with                365 nm               white light



















           
 
Figure S5  Photochemistry of compound 2e in DMSO: A) Extract from 
1
H NMR spectra before and after irradiation 
with UV light at λ = 365 nm (c ≈ 2 mM). B) UV-Vis absorption spectra before and after irradiation with UV light at 
λ = 365 nm (c ≈ 30 μM). C) Reversible photochromism. D) Thermal cis-trans isomerization at 37 °C. 
                           
 
Figure S6  Photochemistry of compound 2f in DMSO: A) Extract from 
1
H NMR spectra before and after irradiation 
with UV light at λ = 365 nm (c ≈ 2 mM). B) UV-Vis absorption spectra before and after irradiation with UV light at 
λ = 365 nm (c ≈ 30 μM). C) Reversible photochromism. D) Thermal cis-trans isomerization at 37 °C. 
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Figure S7  Photochemistry of compound 2g in DMSO: A) Extract from 
1
H NMR spectra before and after irradiation 
with UV light at λ = 365 nm (c ≈ 2 mM). B) UV-Vis absorption spectra before and after irradiation with UV light at 
λ = 365 nm (c ≈ 30 μM). C) Reversible photochromism. D) Thermal cis-trans isomerization at 37 °C. 
   
 
Figure S8  Photochemistry of compound 2j in DMSO: A) Extract from 
1
H NMR spectra before and after irradiation 
with UV light at λ = 365 nm (c ≈ 2 mM). B) UV-Vis absorption spectra before and after irradiation with UV light at 
λ = 365 nm (c ≈ 30 μM). C) Reversible photochromism. D) Thermal cis-trans isomerization at 37 °C. 
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Figure S9  A) Extract from 
1
H NMR spectra of compound 2h before and after irradiation with UV light at 
λ = 365 nm in DMSO-d6 (c ≈ 2 mM) that shows degradation occurring upon irradiation besides photoisomerization. 
 
 
Figure S10  Photochemistry of compound 2i in DMSO: A) Extract from 
1
H NMR spectra before and after 
irradiation with UV light at λ = 365 nm (c ≈ 2 mM). B) UV-Vis absorption spectra before and after irradiation with 
UV light at λ = 365 nm (c ≈ 30 μM). C) Reversible photochromism. D) Thermal cis-trans isomerization at 37 °C. 
            
Figure S11  A) UV-Vis absorption spectra of compound 2i in aqueous buffer at pH = 7.4 with 1.5 vol% DMSO 
before and after successive irradiation with UV light at λ = 365 nm and white light (c ≈ 30 μM). Light scattering 
evident in the spectra indicates a degree of aggregation of the compound in its trans form that is dissolved upon 
photoisomerization with UV light at λ = 365 nm and reestablished upon cis-trans isomerization with white light. B) 
UV-Vis absorption spectra of compound 2j in aqueous buffer at pH = 7.4 with 0.25 vol% DMSO before irradiation 
and after successive irradiation with UV light at λ = 365 nm and white light (c ≈ 5 μM). Effects of aggregation are 
no longer evident here at lower concentration. 
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 Figure S12  A) Reversible photochromism of compound 2i in aqueous buffer at pH = 7.4 with 0.25 vol% DMSO at 
37 °C and c ≈ 5 μM. B) Thermal cis-trans isomerization of 2i under the same conditions. 
 
Figure S13  Further attempt at half-life determination of 2i in aqueous buffer at pH = 7.4 with 1 vol% DMSO at 
37 °C and c ≈ 10 M. After partial thermal cis-trans isomerization compound 2i starts to aggregate/precipitate 
which makes the measurement of a reliable half-life difficult, especially at  c > 5 M. 
 
 
Figure S14  UV/Vis absorption spectra of selected compounds 2b (A) 2e (B) and 2g (C) in aqueous buffer at pH = 
7.4 with 1.5 vol% DMSO (c ≈ 30 μM) before and after irradiation with UV light at λ = 365 nm, showing light 
scattering likely due to aggregation, especially of the trans isomers. 
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Photoisomerization of red-shifted diaminopyrimidines 12 and 13 
 
 
Figure S15  Photoisomerization of compound 12: A) UV-Vis absorption spectra before and after irradiation with 
green light at λ = 527 nm (2 min) and violet light at λ = 400 nm (2 min) in DMSO (c ≈ 30 μM). B) UV-Vis 
absorption spectra before and after irradiation with green light at λ = 527 nm (over 6 min) and violet light at 
λ = 400 nm (2 min) in aqueous LB broth with 1.5 vol% DMSO (c ≈ 30 μM). C) Reversible photochromism in 
aqueous LB broth with 1.5 vol% DMSO at 37 °C (c ≈ 30 μM). D) Extract from 1H NMR spectra before and after 





Figure S16  UHPLC-MS analysis of compound 12 before (A) and after (B) irradiation with green light at 
λ = 527 nm for 30 min in aqueous buffer at pH = 7.4 with 0.5 vol% DMSO at c ≈ 80 μM. Chromatograms show 
detection by UV-Vis absorption trace at λ = 425 nm. MS traces correspond to signals at: 9.33 min and 9.49 min (A), 
9.30 min and 9.51 min (B). 
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Figure S17  Photoisomerization of compound 13 in DMSO: UV-Vis absorption spectra before and after irradiation 
with A) green light at λ = 527 nm for 10 min; B) white light at λ ≥ 530 nm for 10 min; C) red light at λ = 652 nm for 
2 h (c ≈ 40 μM). D) Extract from 1H NMR spectra before and after irradiation with various light sources 
(λ = 527 nm: 1 h, white light at λ ≥ 530 nm: 1 h, λ = 652 nm: 3 h, λ = 400 nm: 30 min) in DMSO-d6 (c ≈ 2 mM). 
 
 
Figure S18  Photoisomerization of compound 13 in aqueous LB broth: UV-Vis absorption spectra before and after 
irradiation with white light at λ ≥ 530 nm over 10 min and violet light at λ = 400 nm for 5 min at A) c ≈ 40 μM 
(2 vol% DMSO) and B) c ≈ 15 μM (0.75 vol% DMSO). C) Reversible photochromism at 37 °C (c ≈ 15 μM, 
0.75 vol% DMSO). 
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 Figure S19  Photoisomerization of compound 13 in DMSO and c ≈ 100 μM: UV-Vis absorption spectra before and 
after irradiation with A) red light at λ = 652 nm and B) with white light using a 650 nm cutoff filter. C) Absorbance 




Figure S20  UHPLC-MS analysis of compound 13 before (A) and after (B) irradiation with red light at λ = 652 nm 
for 2.5 h in aqueous buffer at pH = 7.4 at c ≈ 80 μM with 0.5 vol% DMSO. Chromatograms show detection by UV-
Vis absorption trace at λ = 405 nm. MS traces correspond to signals at: 9.86 min and 10.21 min (A), 9.83 min and 
10.23 min (B). 
 
Figure S21  Increasing concentrations of  compound 13 (20 
°




Thermal half-lifes of cis-12 and cis-13: Because of the high thermal stability of the cis isomers of 
diaminopyrimidines 12 and 13, an approximation of its thermal half-life via UV-Vis was not 
feasible. UHPLC-MS analysis of a sample of 12 that was irradiated with green light at λ = 527 nm 
in aqueous buffer at pH = 7.4 and subsequently left standing at room temperature in the dark for a 
day confirmed a half-life of well over 24 h in water (figure S22). The same could be shown for 13 






Figure S22  UHPLC-MS analysis of A) compound 12 after irradiation with green light at λ = 527 nm for 30 min in 
aqueous buffer at pH = 7.4 with 0.5 vol% DMSO at c ≈ 80 μM and B) the same sample after standing for 24 h at 
room temperature in the dark. Chromatograms show detection by UV-Vis absorption trace at λ = 425 nm. MS traces 
correspond to signals at: 9.30 min and 9.51 min (A), 9.23 min and 9.44 min (B). 
A B 
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Figure S23  UHPLC-MS analysis of A) compound 13 after irradiation with red light at λ = 652 nm for 2.5 h in 
aqueous buffer at pH = 7.4 with 0.5 vol% DMSO at c ≈ 80 μM and B) the same sample after standing for 24 h at 
room temperature in the dark. Chromatograms show detection by UV-Vis absorption trace at λ = 405 nm. MS traces 
correspond to signals at: 9.83 min and 10.23 min (A), 11.17 min and 11.46 min (B). 
A B 
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 Figure S24  Reversible photosisomerization of 2i (37 
°
C, buffer with 1 vol% DMSO at pH = 7.4, 20 M) in the 
presence of 10 mM glutathione (GSH). 5 cycles of 365 nm/white light irradiation could be performed without the 
observation of significant fatigue or reduction.  
 
 
Figure S25  Reversible photosisomerization of 12 (37 
°
C, buffer with 1 vol% DMSO at pH=7.4, 20 M) in the 
presence of 10 mM glutathione (GSH). 5 cycles of 530 nm/400 nm irradiation could be performed without the 
observation of significant fatigue or reduction.   
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Antibiotics Assays 
Bacterial strain and growth conditions. E. coli CS1562 was grown in Luria Bertani (LB) medium 
(5 g/L yeast extract; 10 g/L tryptone; 5 g/L NaCl) supplemented with tetracycline (10 g/mL)  at 
37 °C . 
Antibacterial activity and bacterial growth curves. Overnight cultures of E. coli CS1562 were 
diluted to an OD650 of  0.1 and 100 μl of this cell suspension was added to 100 μl medium 
containing antibiotics at the given concentrations. To determine the antibacterial activity after 
photoisomerization, the solutions were first irradiated with UV light at λ = 365 nm for 15 min 
(compounds 2a-j) or with green light at λ = 527 nm for 30 min (red-shifted derivative 12) prior to 
adding the cell suspension. In case of diaminopyrimidine 12 irradiation was also performed in situ 
after addition of the cell suspension. For red-shifted derivative 13, a 16 mM stock solution in 
DMSO was divided into two halves and one of them irradiated with red light at λ = 652 nm for 
2.5 h. Cells were grown in a microtiter plate at 37 °C and cell density (λ = 650 nm) was measured 
every 2 min for 16 h, with a 10 s shaking step before each measurement, in a microplate reader 
(Synergy H1, BioTek). Graphs were background-corrected by subtracting the OD650 at time 0. MIC 
values were calculated by plotting the OD650 against the concentrations of the used antibiotics in a 
two-fold dilution series. The MIC90 values were determined after 16 h incubation and represent the 
concentration at which the OD650 is < 10% of the blank sample.  
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Figure S26  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 2a. Samples after irradiation 
with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
 
 
Figure S27  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 2b. Samples after irradiation 
with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
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Figure S28  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 2c. Samples after irradiation 
with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
 
     
Figure S29  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 2d. Samples after irradiation 
with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
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Figure S30  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 2e. Samples after irradiation 
with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
 
         
Figure S31  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 2f. Samples after irradiation 
with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
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 Figure S32  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 2g. Samples after irradiation 
with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 




Figure S33  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 2i. Samples after irradiation 
with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
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 Figure S34  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 2j. Samples after irradiation 
with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
 
          
Figure S35  Bacterial growth curves of E. coli CS1562 at increasing concentrations of trimethoprim (1). Samples 
after irradiation with UV light at λ = 365 nm are presented as solid lines. Samples after thermal adaptation are 
presented as dashed lines. Error bars show s.d. calculated from measurements in triplicate. 
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 Figure S36  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 12. Samples after irradiation 
with green light at λ = 527 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
 
 
Figure S37  Bacterial growth curves of E. coli CS1562 at increasing concentrations (narrowed concentration 
window) of 12. Samples after irradiation with green light at λ = 527 nm are presented as solid lines. Samples after 
thermal adaptation are presented as dashed lines. Error bars show s.d. calculated from measurements in triplicate. 
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 Figure S38  Bacterial growth curves of E. coli CS1562 at increasing concentrations (narrowed concentration 
window) of 12. Irradiation was performed in situ in the presence of bacteria. Samples after irradiation with green 
light at λ = 527 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed lines. Error 
bars show s.d. calculated from measurements in triplicate. 
 
 
Figure S39  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 13. Samples after irradiation 
with red light at λ = 652 nm are presented as solid lines. Samples after thermal adaptation are presented as dashed 
lines. Error bars show s.d. calculated from measurements in triplicate. 
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 Figure S40  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 13. Irradiation was 
performed on a 16 mM solution in DMSO for 2.5 h with red light at λ = 652 nm before a twofold dilution series in 
LB was made. Samples after irradiation are presented as solid lines. Samples after thermal adaptation are presented 
as dashed lines. Error bars show s.d. calculated from measurements in triplicate. 
 
Figure S41  Bacterial growth curves of E. coli CS1562 at increasing concentrations of 13. Irradiation was 
performed on a 16 mM solution in DMSO for 3 h with red light at λ = 652 nm before a two-fold dilution series in 
LB was made. Subsequently, after inoculation with bacteria, half of the 96-well plate was covered and irradiated 
with λ = 400 nm for 30 min. OD650 was measured every 2 minutes for 16 h at 37 °C. Samples after irradiation with 
violet light at λ = 400 nm are presented as solid lines. Samples not irradiated with violet light are presented as 
dashed lines. Error bars show s.d. calculated from measurements in triplicate. 
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Chemical actinometry and quantum yield determination 
An aqueous 0.05 M H2SO4 solution containing 6 mM, 12 mM and 150 mM K3[Fe(C2O4)3]  (2 or 
3 mL, 1 cm quartz cuvette), respectively for 365, 400 and 527 nm, was irradiated at 20 °C for a  
given period of time in the dark with the respective wavelength.  A volume of 20, 10, 20 L was 
taken respectively for 365, 400 and 527 nm and diluted to 2.0 mL with an aqueous 0.5 M H2SO4 
solution containing phenanthroline (1 g/L) and NaOAc (122.5 g/L). The absorption at λ = 517 nm 
was measured and compared to an identically prepared non-irradiated sample. The concentration of 
[Fe(phenanthroline)3]
2+
 complex was calculated using its molar absorptivity (Ɛ = 11100 m–1 cm–1). 
This concentration corresponded to the concentration of Fe
2+
 ions that had formed upon irradiation 
divided by 100, 200, 100 respectively for 365, 400 and 527 nm. For 527 nm the probabililty factor 
at λ = 527 nm was taken into account15 and the theoretical concentration of Fe2+ formed upon 





concentration was plotted versus time and the following slope, obtained by linear fitting to the 
equation y = ax + b using Origin software (S42-S44), equals the rate of formation for the given 
wavelengths at standardized conditions. These rates can be converted in light doses by taking into 
account the quantum yield and area of irradiation which is 2, 3 and 3 cm
2
 respectively for 365, 400 
and 530 nm. Subsequently, the energy per moles of photons at a given wavelength (Emole of photons= 






A solution of (trans)-2i was irradiated with the Thorlab model F365F1 high-power LED under 
identical standardized conditions as with the actinometry at concentrations high enough to absorb 
all incident light (absorbance at 365 ≥ 2). The absorbance decrease at λ = 385 nm was monitored 
over time by UV-Vis spectroscopy. The molar absorptivities at λ = 365 nm [(trans)-2i, 








] were used to calculate the concentration 
increase of (cis)-2i according to Δc = Δabs/(Ɛtrans + Ɛcis). The initial concentration increase was 
plotted versus time (S45) and the slope, the rate of formation of cis isomer over time, was obtained 
by linear fitting to the equation y = ax + b using Origin software. The photochemical quantum yield 
for 2i (ɸ trans-cis) was calculated by comparison of the rate of formation of (cis)-2i with the rate of 
Fe
2+
 ion formation at identical conditions upon 365 nm irradiation from potassium ferrioxalate 
using the known quantum yield for the ferrioxalate at the given wavelength (ɸ = 1.21).16,17 
                                                 
15
 S. L. Hopkins, Siewert, S. H. C. Askes, P. Veldhuizen, R. Zwier, Michal Hegerc, Sylvestre Bonnet, Photochem. 
Photobiol. Sci. , 15, 644. 
16
 C. G. Hatchard, C. A. Parker, Proc. R Soc. Lond. A Math. Phys. Eng. Sci. 1956, 235, 518. 
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Calculation of the quantum yield for the reverse reaction at 365 nm can be performed following 




Figure S42  Concentration of Fe
2+
 ions measured after five different irradiation times (10, 20, 30, 40, 50 s) with 
400 nm light. The slope of the plot corresponds to the rate of Fe
2+













 ± 3.24 x 10-8 mole s
-1
. Following ɸ(ferrioxalate at 400 nm) = 1.14 and the area of 
irradiation = 3 cm
2
 and E(mole of photons at 400 nm) = 2.99 x 10
5








                                                                                                                                                                  
17
 M. Montalti, A. Credi, L. Prodi, M. T. Gandolfi, Handbook of Photochemistry, Third Edition, (CRC Press, 2006). 
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 Figure S43  Concentration of Fe
2+
 ions measured after six different irradiation times (10, 30, 40, 50, 60, 70 s) with 
365 nm light. The slope of the plot corresponds to the rate of Fe
2+

















. Following ɸ(ferrioxalate at 365 nm)= 1.21 and the area of irradiation 
= 2 cm
2
 and E(mole of photons at 365 nm) = 3.28 x 10
5








Figure S44  Concentration of Fe
2+
 ions measured after seven different irradiation times (10, 20, 30, 40, 50, 60, 90 s) 
with 527 nm light. The slope of the plot corresponds to the rate of Fe
2+

















. Following ɸ(ferrioxalate at 527 nm)= 0.53 and the area of 
irradiation = 3 cm
2
 and E(mole of photons at 527 nm) = 2.27 x 10
5








 Figure S45  Plot of the concentration of (cis)-2i as a function of time during λmax = 365 nm irradiation of a solution 
of (trans)-2i in DMSO (c = 1.33 × 10
–4
 M, 1 cm quartz cuvette) obtained by monitoring the absorption decrease at λ 

















. Correlation of this rate to the rate of ferrioxalate consumption at these 
standardized conditions with 365 nm and the ferrioxalate quantum yield at the given wavelength gives a quantum 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































13C NMR (151 MHz, DMSO-d6) of 13
S88
